Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105 000 people of more than 140 nationalities work at Novartis around the world.

In the UK, we employ approximately 1,300 people to serve healthcare needs across the whole of the UK, as well as supporting the global operations of Novartis. Since 2014, Novartis has invested over £200 million in R&D and is the single largest industry sponsor of clinical trials in the UK.

Community healthMay 10, 2021
Population health management: the time is now
While the adoption of population health management is still in its infancy, and there is a need for more evidence and better exchange mechanisms to share it, can localities really afford not to try?
Health PolicyNovember 25, 2020
The digital revolution of health and care: From the fax machine to Zoom
The Covid-19 pandemic has accelerated the digital transformation of health and care. However, the implementation of this digital transition represents a monumental challenge for the healthcare sector. How can we harness this momentum and continue to deliver digital transformation at pace?

Become a Partner

If you would like to enquire about a media partnership with ICJ, please contact carl.hodgkinson@dorsonwest.com for more information.
Integrated Care Journal
  • 0207 8399305

ISSN Number: 2517-2662